PNC Financial Services Group’s Mirum Pharmaceuticals MIRM Stock Holding History
Bought
Maintained
Sold
Other funds holding MIRM
PNC Financial Services Group's MIRM Position: Q3 2026 in Review
PNC Financial Services Group increased its Mirum Pharmaceuticals (MIRM) stake by 1.6% in Q3 2026, buying an estimated $2.71K and bringing the position to 1,615 shares worth $138K. The position accounts for ﹤0.01% of the portfolio, ranked #2750.
PNC Financial Services Group first reported a position in MIRM in Q2 2022 and has held it in 17 quarters since. The position peaked at $186K in Q2 2026. 251 funds tracked by Wall St. Rank hold MIRM as of Q3 2026.
- PNC Financial Services Group held 1,615 shares of Mirum Pharmaceuticals worth $138K as of Q3 2026.
- PNC Financial Services Group bought 26 Mirum Pharmaceuticals shares in Q3 2026, an estimated $2.71K.
- Mirum Pharmaceuticals made up ﹤0.01% of PNC Financial Services Group's portfolio in Q3 2026, its #2750 holding.
- PNC Financial Services Group first reported a position in Mirum Pharmaceuticals in Q2 2022 and has held it in 17 quarters since.
- PNC Financial Services Group's Mirum Pharmaceuticals position peaked at $186K in Q2 2026.
- 251 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q3 2026.
Based on PNC Financial Services Group's 13F filing for Q3 2026, filed 6 Nov 2026.